One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling

Funding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology platform, to guide treatment decisions, patient selection, therapy development, and optimize clinical trialsProceeds will also help scale strategic partnerships with pharmaceutical and biotechnology companiesFinancing led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures and Kima VenturesView original content:https://www.prnewswire.co.uk/news-releases/one-biosciences-announces-15-million-series-a-financing-to-advance-clinical-single-cell-profiling-302507084.html